| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/26/2009 | US20090055941 Novel Neural Cell Specific Promoter And Baculovirus And Method For Gene Delivery |
| 02/26/2009 | US20090054624 useful in the treatment of a condition which is responsive to the PRO polypeptide, an agonist or antagonist thereof or an anti-PRO antibody |
| 02/26/2009 | US20090054500 Composition and methods useful in preventing cardiac hypertrophy |
| 02/26/2009 | US20090054438 Compositions and methods for inhibiting growth and metastasis of melanoma |
| 02/26/2009 | US20090054366 RNAi MEDIATED KNOCKDOWN OF NUMA FOR CANCER THERAPY |
| 02/26/2009 | US20090054364 treating bladder cancer; transfecting with polynucleotide into urothelial cells; improved transfection efficiency with cationic lipids, cationic polymers or dendrimers; improve drug delivery with a solubilized cholesterol |
| 02/26/2009 | US20090054358 Flt3 inhibitors for immune suppression |
| 02/26/2009 | US20090054337 Natriuretic polypeptides |
| 02/26/2009 | US20090054336 Binding Agent |
| 02/26/2009 | US20090054328 Reagents and Methods for Modulating Gene Expression Related to Hypertension |
| 02/26/2009 | US20090054325 Compositions and methods for suppressing axonal growth inhibition |
| 02/26/2009 | US20090054323 Ang-2 inhibitor peptides; use treating tumors, eye disorders, bone disorders, psoriasis; angiogenesis inhibitors; amino acid sequence WDPWT |
| 02/26/2009 | US20090054321 Polypeptides and use thereof |
| 02/26/2009 | US20090054320 Vesiculins |
| 02/26/2009 | US20090054316 Agent for control of function of antigen-presenting cell |
| 02/26/2009 | US20090054306 which binds to cell through ligand and activated by emitted light; photosensitizer is hematoporphyrin; transport ligand is peptide; conjugate of transferrin-hematoporphyrin which destroys cancerous cells in presence of luminol; tissue targeted |
| 02/26/2009 | US20090054300 Using protein profiles aspredictive tools in prognosis and treatment of immune related disorders |
| 02/26/2009 | US20090054259 Methods for inducing complete apoptosis of liver cells expressing hbchi protein and screening for substances or genes that inhibit the apoptosis |
| 02/26/2009 | US20090054247 Polynucleotides encoding proteins involved in plant metabolism |
| 02/26/2009 | US20090054244 Nucleic acid molecule encoding a novel estrogen receptor beta variant |
| 02/26/2009 | US20090054241 Method for the Preparation of a Composition Based on 4-Hydroxyproline and the Uses Thereof in the Agronomical Field |
| 02/26/2009 | US20090053812 Scleral cell strain |
| 02/26/2009 | US20090053811 Reactor Comprising an Annular Reaction Space |
| 02/26/2009 | US20090053810 System and Method for Cultivating Cells |
| 02/26/2009 | US20090053809 Retina-Specific Cells Differentiated In Vitro from Bone Marrow Stem Cells, the Production Thereof and Their Use |
| 02/26/2009 | US20090053807 Insulin and IGF-1 Receptor Agonists and Antagonists |
| 02/26/2009 | US20090053806 Coating solution and method for capturing and preserving biological materials |
| 02/26/2009 | US20090053805 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 02/26/2009 | US20090053804 Methods of reducing intracellular fats from mammalian cells |
| 02/26/2009 | US20090053803 Apparatus and method for harvesting biologics from eggs |
| 02/26/2009 | US20090053802 Multipotent stem cells from peripheral tissues and uses thereof |
| 02/26/2009 | US20090053791 Methods and composition for the production of orthogonal tRNA-aminoacyl tRNA synthetase pairs |
| 02/26/2009 | US20090053790 Polypeptide Having Affinity for Envelope Virus Constituent and Use Thereof in Transferring Substance Into Cell |
| 02/26/2009 | US20090053786 Prevention of disulfide bond reduction during recombinant production of polypeptides |
| 02/26/2009 | US20090053766 Methods and compositions for producing recombinant proteins using a gene for trna |
| 02/26/2009 | US20090053764 Salutaridinol 7-0-Acetyltransferase and Derivatives Thereof |
| 02/26/2009 | US20090053763 Tumor endothelial marker 7-alpha molecules and uses thereof |
| 02/26/2009 | US20090053762 Cell/tissue culturing device, system and method |
| 02/26/2009 | US20090053758 Processes for clonal growth of hepatic progenitor cells |
| 02/26/2009 | US20090053752 Use of an in vitro hemodynamic endothelial/smooth muscle cell co-culture model to identify new therapeutic targets for vascular disease |
| 02/26/2009 | US20090053750 Methods and compositions for identifying a cellular immune response against prostate cancer |
| 02/26/2009 | US20090053748 Cytochrome c protein and assay |
| 02/26/2009 | US20090053740 Agglutination-based method for fast detection, isolation and quantification of apoptotic cells |
| 02/26/2009 | US20090053737 Monoclonal Antibody Which Binds Met In Formalin-Fixed and Paraffin-Embedded Tissues and Related Methods |
| 02/26/2009 | US20090053735 Vector expressing n-deacetylase/n-sulfotransferase 2 |
| 02/26/2009 | US20090053730 Chimeric human t1r1 taste receptor polypeptides and compositions containing same |
| 02/26/2009 | US20090053712 Methods of using LEDGF/p75 |
| 02/26/2009 | US20090053701 Detectable nucleic acid tag |
| 02/26/2009 | US20090053691 Cell Line and Methods for Determining Viral Titer |
| 02/26/2009 | US20090053311 Pharmaceutical Compositions for Treating or Preventing Bone Conditions |
| 02/26/2009 | US20090053300 Monoclonal antibody, gene encoding the antibody, hybridoma, pharmaceutical composition, and diagnostic reagent |
| 02/26/2009 | US20090053298 constitutive active/androstane receptor (CAR); antisense agents; drug screening; hepatocytes |
| 02/26/2009 | US20090053295 Regulatable fusion promoters |
| 02/26/2009 | US20090053292 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof |
| 02/26/2009 | US20090053282 Bone Grafting Method and Kit |
| 02/26/2009 | US20090053277 Cell Sheet Containing Mesenchymal Stem Cells |
| 02/26/2009 | US20090053265 Antigenic peptides and their use |
| 02/26/2009 | US20090053256 inducing an immune response to a poxvirus in a mammal by administering a composition comprising a nucleic acid molecule comprising nucleotide sequence encoding a variola F8 polypeptide, wherein nucleotide sequence is codon optimized for expression in both a mammalian cell and a bacterial cell |
| 02/26/2009 | US20090053253 Process for the measurement of the potency of glatiramer acetate |
| 02/26/2009 | US20090053252 Bimer or an oligomer of a dimer, trimer, quatromer or pentamer of recombinant fusion proteins |
| 02/26/2009 | US20090053251 Dendritic Cell Compositions and Methods |
| 02/26/2009 | US20090053249 Specific Inhibition of Autoimmunity and Diseases Associated With Autoantigens |
| 02/26/2009 | US20090053248 Compositions and methods for transepithelial molecular transport |
| 02/26/2009 | US20090053244 Modified vaccinia virus strains for use in diagnostic and therapeutic methods |
| 02/26/2009 | US20090053243 Anti-IgSF4 Antibody and Utilization of the Same |
| 02/26/2009 | US20090053241 inhibition of platelet derived growth factor receptor-beta (PDGFR beta ) on angiogenesis, and provides for treatment of angiogenesis; |
| 02/26/2009 | US20090053239 ACACS As Modifiers of the IGF Pathway and Methods of Use |
| 02/26/2009 | US20090053233 Cytotoxic Antibody Directed Against Type B Lymphoid Hematopoietic Proliferations |
| 02/26/2009 | US20090053231 Optical Disc Apparatus |
| 02/26/2009 | US20090053230 Anti-ox40l antibodies and methods using same |
| 02/26/2009 | US20090053228 Lawsonia intracellularis subunit vaccines |
| 02/26/2009 | US20090053227 Prostate Specific Genes and The Use Thereof in Design of Therapeutics |
| 02/26/2009 | US20090053226 Compositions and methods for the treatment of tumor of hematopoietic origin |
| 02/26/2009 | US20090053225 Recombinant antibodies against cd55 and cd59 and uses thereof |
| 02/26/2009 | US20090053224 Lox and loxl2 inhibitors and uses thereof |
| 02/26/2009 | US20090053215 Cytotoxicity mediation of cells evidencing surface expression of CD63 |
| 02/26/2009 | US20090053213 for inflammatory diseases such as rheumatoid arthritis; GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor); |
| 02/26/2009 | US20090053210 Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals |
| 02/26/2009 | US20090053209 Blockade of Pin1 Prevents Cytokine Production by Activated Immune Cells |
| 02/26/2009 | US20090053208 Methods and Systems for Improving Tissue Perfusion |
| 02/26/2009 | US20090053202 Peptide fragment of LYVE-1 and antibody against the same |
| 02/26/2009 | US20090053198 Cytokine Induction of Selectin Ligands on Cells |
| 02/26/2009 | US20090053191 Phospholipases, nucleic acids encoding them and methods for making and using them |
| 02/26/2009 | US20090053185 Coagulation factor x polypeptides with modified activation properties |
| 02/26/2009 | US20090053184 Compositions comprising t cell receptors and methods of use thereof |
| 02/26/2009 | US20090053183 Treatment of Diseases and Disorders Using Self-Renewing Colony Forming Cells Cultured and Expanded In Vitro |
| 02/26/2009 | US20090053182 Endometrial stem cells and methods of making and using same |
| 02/26/2009 | US20090053181 Modulation of Cells |
| 02/26/2009 | US20090053180 Tandem cardiac pacemaker system |
| 02/26/2009 | US20090053170 Human prostate cell lines in cancer treatment |
| 02/26/2009 | US20090053147 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules |
| 02/26/2009 | US20090050136 Transgenic plant cells and plants having modified activity of the gbssi and of the be protein |
| 02/26/2009 | DE102007040370A1 Kollagenhaltiger Zellträger Collagen-cell support |
| 02/26/2009 | DE102007039429A1 Verfahren zur Aktivierung regulatorischer T-Zellen A process for the activation of regulatory T cells |
| 02/26/2009 | CA2842980A1 Collagen-containing cell carrier |
| 02/26/2009 | CA2734549A1 Anti-idiotypic antibodies which neutralise the inhibitory activity of an inhibitory antibody directed against the c1 domain of factor viii |
| 02/26/2009 | CA2700463A1 Use of eif-5a1 sirna to protect islets cells from apoptosis and to preserve their functionality |
| 02/26/2009 | CA2696801A1 Generation of neuronal cells from pluripotent stem cells |
| 02/26/2009 | CA2696701A1 Cdca1 peptide and pharmaceutical agent comprising the same |
| 02/26/2009 | CA2696684A1 Pthrp, its isoforms and antagonist thereto in the diagnosis and treatment of disease |